Invention Grant
- Patent Title: Aerosol formulation for COPD
-
Application No.: US17019740Application Date: 2020-09-14
-
Publication No.: US11590074B2Publication Date: 2023-02-28
- Inventor: Sauro Bonelli , Francesca Usberti , Enrico Zambelli
- Applicant: CHIESI FARMACEUTICI S.p.A.
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP09015980 20091223
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/167 ; A61K31/40 ; A61K31/573 ; A61K45/06 ; A61P11/00 ; A61K47/06 ; A61K47/10 ; B65B31/06 ; B65B31/10
Abstract:
Stable aerosol solution formulations comprising glycopyrronium bromide are useful for administration to patients with COPD and other respiratory conditions.
Public/Granted literature
- US20210000738A1 AEROSOL FORMULATION FOR COPD Public/Granted day:2021-01-07
Information query
